COMPARATIVE TISSUE CONCENTRATION PROFILES OF FENTANYL AND ALFENTANIL IN HUMANS PREDICTED FROM TISSUE BLOOD PARTITION DATA OBTAINED IN RATS

被引:60
作者
BJORKMAN, S
STANSKI, DR
VEROTTA, D
HARASHIMA, H
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT ANESTHESIOL,STANFORD,CA 94305
[2] VET ADM MED CTR,PALO ALTO,CA 94304
关键词
Analgesics: alfentanil; fentanyl; Pharmacokinetics: distribution; kinetics; models; uptake; Solubility: partition coefficients;
D O I
10.1097/00000542-199005000-00017
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The steady-state tissue/blood partition coefficients of fentanyl and alfentanil were determined in 13 organs and tissues in the rat. A 6-h infusion of both drugs was used in order to achieve steady-state. Blood and tissue concentrations of drugs were measured by gas-liquid chromatography. The partition coefficients of fentanyl were two- to 30-fold higher than those of alfentanil. These data were then used in a physiologic pharmacokinetic model describing the disposition of the two opioids in humans. The model predicted the plasma pharmacokinetics of these drugs in humans reasonably well. However, simulation beyond 24 h after a bolus administration showed a terminal half-life of 20 h for fentanyl, i.e., an elimination phase that has not yet been described in actual pharmacokinetic studies. In keeping with this, the volume of distribution of fentanyl in the model was also larger than expected. The simulated tissue concentration curves of fentanyl and alfentanil in humans could be used to explain the propensity of fentanyl to give secondary peaks in plasma concentration curves and the difference in effect kinetics between the two opioids. Physiologic pharmacokinetic modeling, based on measured data in small animals, can generate information that is not obtainable by empirical methods in humans.
引用
收藏
页码:865 / 873
页数:9
相关论文
共 26 条
[1]  
BISCHOFF KB, 1975, CANCER CHEMOTH REP 1, V59, P777
[2]   SIMULTANEOUS DETERMINATION OF FENTANYL AND ALFENTANIL IN RAT-TISSUES BY CAPILLARY COLUMN GAS-CHROMATOGRAPHY [J].
BJORKMAN, S ;
STANSKI, DR .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 433 :95-104
[3]   COMPARATIVE PHARMACOKINETICS OF FENTANYL AND ALFENTANIL [J].
BOWER, S ;
HULL, CJ .
BRITISH JOURNAL OF ANAESTHESIA, 1982, 54 (08) :871-877
[4]   THE UPTAKE OF FENTANYL BY ERYTHROCYTES [J].
BOWER, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (03) :181-185
[5]  
BOXENBAUMH, 1986, J PHARM SCI, V11, P1053
[6]   MEAN RESIDENCE TIME THEORETICAL DEVELOPMENT, EXPERIMENTAL-DETERMINATION, AND PRACTICAL USE IN TRACER ANALYSIS [J].
COVELL, DG ;
BERMAN, M ;
DELISI, C .
MATHEMATICAL BIOSCIENCES, 1984, 72 (02) :213-244
[8]  
EVANS GH, 1973, J PHARMACOL EXP THER, V186, P114
[9]   PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING - PRINCIPLES AND APPLICATIONS [J].
GERLOWSKI, LE ;
JAIN, RK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (10) :1103-1127
[10]   IDENTIFICATION AND QUANTITATIVE-DETERMINATION OF FENTANYL METABOLITES IN PATIENTS BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
GOROMARU, T ;
MATSUURA, H ;
YOSHIMURA, N ;
MIYAWAKI, T ;
SAMESHIMA, T ;
MIYAO, J ;
FURUTA, T ;
BABA, S .
ANESTHESIOLOGY, 1984, 61 (01) :73-77